EUVIMEDEUVIMED entdecken
Open Access

Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT

Lanlan Zhou, Leiqing Zhang, Jun Zhang, Laura Jinxuan Wu, Shengliang Zhang, Andrew George, Marina Hahn, Howard P Safran, Clark C Chen, Attila A Seyhan, Eric T Wong, Wafik S El-Deiry

Oncotarget · 2025

DOI: 10.18632/oncotarget.28707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, 2025. Verfasst von Lanlan Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, RI 02903, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, DNA Repair Enzymes, DNA Modification Methylases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaDNA Repair EnzymesDNA Modification MethylasesPyridonesTumor Suppressor ProteinsAntineoplastic Combined Chemotherapy ProtocolsAnimalsTemozolomideHumansMiceXenograft Model Antitumor AssaysCell Line, TumorDacarbazineApoptosisIsocitrate DehydrogenaseTumor BurdenChemoradiotherapyDisease Models, AnimalPyrimidinesHeterocyclic Compounds, 3-RingImidazolesPyridinesBenzyl Compounds

Stichwörter der Autor:innen

IDHMGMTONC201ONC206glioblastoma multiformeradiotherapytemozolomide

Substanzen

TemozolomideDNA Repair EnzymesDNA Modification MethylasesMGMT protein, humanPyridonesTumor Suppressor ProteinsDacarbazineIsocitrate DehydrogenaseTIC10 compoundONC206

Autor:innen und Institutionen

  • Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, RI 02903, USA.
  • Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, RI 02903, USA.
  • Joint Program in Cancer Biology, Brown University Health System and Brown University, RI 02903, USA.
  • Legorreta Cancer Center at Brown University, RI 02903, USA.
  • Department of Medicine, Hematology/Oncology Division, Brown University Health System and Brown University, RI 02903, USA.
  • Department of Neurosurgery, Brown University Health and Brown University, RI 02903, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Zhou, L., Zhang, L., Zhang, J., Wu, L. J., Zhang, S., George, A., Hahn, M., Safran, H. P., Chen, C. C., Seyhan, A. A., Wong, E. T., & El-Deiry, W. S. (2025). Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT. Oncotarget. https://doi.org/10.18632/oncotarget.28707

Vancouver

Zhou L, Zhang L, Zhang J, Wu LJ, Zhang S, George A, et al. Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT. Oncotarget. 2025. doi:10.18632/oncotarget.28707

BibTeX
@article{Zhou2025,
  author = {Zhou, Lanlan and Zhang, Leiqing and Zhang, Jun and Wu, Laura Jinxuan and Zhang, Shengliang and George, Andrew and Hahn, Marina and Safran, Howard P and Chen, Clark C and Seyhan, Attila A and Wong, Eric T and El-Deiry, Wafik S},
  title = {Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT},
  journal = {Oncotarget},
  year = {2025},
  doi = {10.18632/oncotarget.28707}
}
Kostenlos starten →